Clinical Trial

Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke

Name: Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke — clinical trial record (NCT07279493)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: KPCXM18

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is a multicenter, randomized, double-blind, parallel, placebo-controlled trial design to evaluate the efficacy and safety of the KPCXM18 injection at different doses for the treatment of acute ischemic stroke.

Trial Details

NCT Number	NCT07279493
Lead Sponsor	Kunming Pharmaceuticals, Inc.
Conditions	Acute Ischemic Stroke
Enrollment	300 participants
Start Date	2025-11-22
Primary Completion	2026-10-18 (estimated)
Study Completion	2026-10-18 (estimated)
Updated on ClinicalTrials.gov	2025-12-12